American Century Companies Inc Exelixis, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 463,615 shares of EXEL stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

463,615

Previous 440,004 5.37%

Holding current value

$15.4 Million

Previous $9.89 Million 21.69%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.96 - $27.6 $518,497 - $651,663	23,611 Added 5.37%	463,615 $12 Million
Q2 2024 Aug 07, 2024	SELL	$20.34 - $23.73 $37,588 - $43,853	-1,848 Reduced 0.42%	440,004 $9.89 Million
Q1 2024 May 14, 2024	BUY	$20.17 - $23.93 $5.07 Million - $6.01 Million	251,126 Added 131.67%	441,852 $10.5 Million
Q4 2023 Feb 13, 2024	BUY	$19.25 - $24.13 $3.67 Million - $4.6 Million	190,726 New	190,726 $4.58 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $6.44 Million - $7.69 Million	338,021 Added 31.53%	1,410,113 $30.8 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $4.59 Million - $5.17 Million	-252,538 Reduced 19.06%	1,072,092 $20.5 Million
Q1 2023 May 11, 2023	BUY	$16.3 - $19.41 $3.87 Million - $4.6 Million	237,149 Added 21.81%	1,324,630 $25.7 Million
Q4 2022 Feb 13, 2023	SELL	$14.96 - $17.39 $699,006 - $812,547	-46,725 Reduced 4.12%	1,087,481 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $21.1 Million - $30 Million	-1,345,771 Reduced 54.27%	1,134,206 $17.8 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $13.5 Million - $17.9 Million	773,732 Added 45.35%	2,479,977 $51.6 Million
Q1 2022 May 11, 2022	BUY	$17.03 - $22.67 $28.2 Million - $37.5 Million	1,655,090 Added 3235.44%	1,706,245 $38.7 Million
Q4 2021 Feb 07, 2022	SELL	$15.84 - $21.88 $11.2 Million - $15.5 Million	-710,178 Reduced 93.28%	51,155 $935,000
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $10.2 Million - $13.2 Million	-625,233 Reduced 45.09%	761,333 $16.1 Million
Q2 2021 Aug 05, 2021	BUY	$17.95 - $25.56 $24 Million - $34.2 Million	1,336,683 Added 2679.64%	1,386,566 $25.3 Million
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $688,062 - $845,248	33,515 Added 204.76%	49,883 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $9.58 Million - $12.9 Million	-520,728 Reduced 96.95%	16,368 $329,000
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $1.47 Million - $1.91 Million	70,937 Added 15.22%	537,096 $13.1 Million
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $4.47 Million - $7.44 Million	271,419 Added 139.38%	466,159 $11.1 Million
Q1 2020 May 14, 2020	BUY	$14.46 - $21.8 $1.46 Million - $2.2 Million	100,879 Added 107.48%	194,740 $3.35 Million
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $20.8 Million - $25.9 Million	-1,370,776 Reduced 93.59%	93,861 $1.65 Million
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $109,775 - $140,633	6,209 Added 0.43%	1,464,637 $25.9 Million
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $217,713 - $284,649	-11,501 Reduced 0.78%	1,458,428 $31.2 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $5.86 Million - $7.4 Million	-298,999 Reduced 16.9%	1,469,929 $0
Q4 2018 Feb 13, 2019	SELL	$13.65 - $21.8 $9.74 Million - $15.5 Million	-713,234 Reduced 28.73%	1,768,928 $34.8 Million
Q3 2018 Nov 02, 2018	BUY	$15.87 - $22.4 $7.11 Million - $10 Million	447,892 Added 22.02%	2,482,162 $44 Million
Q2 2018 Aug 08, 2018	BUY	$18.56 - $22.45 $31.5 Million - $38.1 Million	1,697,822 Added 504.63%	2,034,270 $43.8 Million
Q1 2018 May 03, 2018	SELL	$22.15 - $31.89 $25.1 Million - $36.1 Million	-1,133,497 Reduced 77.11%	336,448 $7.45 Million
Q4 2017 Feb 02, 2018	BUY	$24.23 - $30.93 $28.9 Million - $36.8 Million	1,190,691 Added 426.38%	1,469,945 $44.7 Million
Q3 2017 Nov 01, 2017	BUY	$23.35 - $29.24 $6.52 Million - $8.17 Million	279,254	279,254 $6.77 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Exelixis, Inc. Transaction History